Rawcliffe Adrian
Insider CIK 1555851 · ADAP Chief Financial Officer, Director · WVE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| WVE Wave Life Sciences, Inc. | A Award deriv | 2026-10-05 | 2026-10-07 | 64,000 | — | $0 | 64,000 | SEC↗ |
| WVE Wave Life Sciences, Inc. | A Award | 2026-10-05 | 2026-10-07 | 10,700 | — | $0 | 10,700 | SEC↗ |
| WVE Wave Life Sciences, Inc. | S Sale | 2026-08-12 | 2026-08-13 | 12,700 | $5.29 | $67.2K | 0 | SEC↗ |
| WVE Wave Life Sciences, Inc. | S Sale | 2026-08-12 | 2026-08-13 | 12,700 | $5.29 | $67.2K | 0 | SEC↗ |
| WVE Wave Life Sciences Ltd. | M Exercise deriv | 2025-12-08 | 2025-12-10 | 42,000 | — | $0 | 0 | SEC↗ |
| WVE Wave Life Sciences Ltd. | M Exercise | 2025-12-08 | 2025-12-10 | 42,000 | $5.97 | $250.7K | 54,700 | SEC↗ |
| WVE Wave Life Sciences Ltd. | S Sale | 2025-12-08 | 2025-12-10 | 42,000 | $15.00 | $630.0K | 12,700 | SEC↗ |
| WVE Wave Life Sciences Ltd. | S Sale | 2025-11-13 | 2025-11-14 | 16,115 | $6.79 | $109.4K | 12,700 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2025-08-11 | 2025-08-13 | 76,200 | — | $0 | 76,200 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award | 2025-08-11 | 2025-08-13 | 12,700 | — | $0 | 28,815 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2025-02-20 | 2025-02-20 | 3,428,832 | — | $0 | 3,428,832 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2025-02-20 | 2025-02-20 | 5,143,248 | — | $0 | 5,143,248 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-01-17 | 2025-01-17 | 30,601 | $0.58 | $17.7K | 44,327 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-01-15 | 2025-01-15 | 29,096 | $0.57 | $16.6K | 41,582 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-01-13 | 2025-01-15 | 17,934 | $0.59 | $10.6K | 25,711 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-01-13 | 2025-01-15 | 12,539 | $0.59 | $7.4K | 17,801 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2024-08-12 | 2024-08-14 | 32,230 | — | $0 | 32,230 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award | 2024-08-12 | 2024-08-14 | 16,115 | — | $0 | 16,115 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-01-17 | 2024-01-17 | 30,080 | $0.67 | $20.2K | 44,848 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-01-16 | 2024-01-17 | 9,304 | $0.79 | $7.4K | 14,104 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-01-15 | 2024-01-17 | 1,696,272 | — | $0 | 1,696,272 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-01-15 | 2024-01-17 | 7,633,296 | — | $0 | 7,633,296 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-01-12 | 2024-01-12 | 17,257 | $0.85 | $14.7K | 26,388 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-01-11 | 2024-01-12 | 11,945 | $0.84 | $10.0K | 18,395 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-09-01 | 2023-09-01 | 2,403 | $0.78 | $1.9K | 3,449 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2023-08-07 | 2023-08-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-06-27 | 2023-06-27 | 2,333 | $0.92 | $2.1K | 3,519 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-01-17 | 2023-01-17 | 1,798,272 | — | $0 | 1,798,272 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-01-17 | 2023-01-17 | 4,690,224 | — | $0 | 4,690,224 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-01-17 | 2023-01-17 | 10,057 | $1.86 | $18.7K | 13,351 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-01-12 | 2023-01-12 | 18,763 | $1.71 | $32.1K | 24,882 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-01-11 | 2023-01-12 | 13,042 | $1.75 | $22.8K | 17,298 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-01-04 | 2023-01-04 | 5,073 | $1.69 | $8.6K | 6,631 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-09-01 | 2022-09-01 | 2,536 | $1.97 | $5.0K | 3,316 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2022-08-15 | 2022-08-17 | 21,000 | — | $0 | 21,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-06-27 | 2022-06-27 | 2,562 | $1.63 | $4.2K | 3,290 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-01-18 | 2022-01-18 | 11,096 | $3.19 | $35.4K | 12,312 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2022-01-12 | 2022-01-13 | 1,047,480 | — | $0 | 1,047,480 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2022-01-12 | 2022-01-13 | 4,690,224 | — | $0 | 4,690,224 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-01-12 | 2022-01-13 | 3,046 | $3.54 | $10.8K | 3,356 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-01-11 | 2022-01-13 | 14,362 | $3.56 | $51.1K | 15,978 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-01-04 | 2022-01-05 | 5,532 | $4.06 | $22.5K | 6,172 | SEC↗ |
| ADAP] Adaptimmune Therapeutics P | S Sale | 2021-09-01 | 2021-09-01 | 2,782 | $5.20 | $14.5K | 3,070 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2021-08-16 | 2021-08-18 | 42,000 | — | $0 | 42,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2021-06-28 | 2021-06-28 | 2,794 | $4.37 | $12.2K | 3,058 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2021-01-19 | 2021-01-19 | 9,879 | $5.67 | $56.0K | 13,529 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2021-01-12 | 2021-01-12 | 2,707 | $6.15 | $16.6K | 3,695 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2021-01-11 | 2021-01-11 | 728,160 | — | $0 | 728,160 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2021-01-11 | 2021-01-11 | 3,260,400 | — | $0 | 3,260,400 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2021-01-04 | 2021-01-05 | 4,967 | $5.33 | $26.5K | 6,737 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2020-09-01 | 2020-09-02 | 2,776 | $8.51 | $23.6K | 3,076 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2020-08-18 | 2020-08-20 | 10,500 | — | $0 | 10,500 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2020-08-03 | 2020-08-04 | 2,788 | $9.25 | $25.8K | 3,064 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2020-01-16 | 2020-01-17 | 2,515,536 | — | $0 | 2,515,536 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2020-01-16 | 2020-01-17 | 561,792 | — | $0 | 561,792 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2020-01-14 | 2020-01-15 | 3,236 | $5.13 | $16.6K | 3,166 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2020-01-06 | 2020-01-07 | 5,900 | $1.20 | $7.1K | 5,804 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-09-01 | 2019-09-03 | 628,872 | — | $0 | 628,872 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-09-01 | 2019-09-03 | 140,448 | — | $0 | 140,448 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2019-08-15 | 2019-08-16 | 10,500 | — | $0 | 10,500 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-06-27 | 2019-06-27 | 628,872 | — | $0 | 628,872 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-06-27 | 2019-06-27 | 140,448 | — | $0 | 140,448 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2019-01-14 | 2019-01-16 | 3,084 | $5.37 | $16.6K | 3,318 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-01-04 | 2019-01-08 | 1,257,744 | — | $0 | 1,257,744 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-01-04 | 2019-01-08 | 280,896 | — | $0 | 280,896 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2018-08-13 | 2018-08-15 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2018-03-20 | 2018-03-22 | 600,000 | $1.71 | $1.03M | 0 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2018-01-12 | 2018-01-17 | 153,648 | — | $0 | 153,648 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2018-01-12 | 2018-01-17 | 687,984 | — | $0 | 687,984 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2017-08-10 | 2017-08-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2017-02-01 | 2017-02-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2017-01-13 | 2017-01-18 | 2,072,976 | — | $0 | 2,072,976 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2016-01-18 | 2016-01-20 | 939,948 | — | $0 | 939,948 | SEC↗ |